Alberto Zanchetti
Abstract
Open-access reader
Since Fleckenstein’s pioneering studies about 35 years ago, calcium channel blockers have become a cornerstone in antihypertensive treatment, thanks to a large number of randomized controlled trial...
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Since Fleckenstein’s pioneering studies about 35 years ago, calcium channel blockers have become a cornerstone in antihypertensive treatment, thanks to a large number of randomized controlled trial...
Key concepts: Medicine, Lercanidipine, Intensive care medicine, Traditional medicine, Internal medicine, Blood pressure